Verona Pharma plc Stock
The community is currently still undecided about Verona Pharma plc with 1 Buy predictions and 0 Sell predictions.
Based on the current price of 0.51 € the target price of 86 € shows a potential of 16929.7% for Verona Pharma plc which would more than double the current price.
Pros and Cons of Verona Pharma plc in the next few years
Pros
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Cons
?
M***** P*******
?
S********** s********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Comments
Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) had its "overweight" rating reaffirmed by analysts at Cantor Fitzgerald. They now have a $100.00 price target on the stock.
Show more
Ratings data for VRNA provided by MarketBeat
Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $170.00 price target on the stock.
Show more
Ratings data for VRNA provided by MarketBeat
Verona Pharma PLC American Depositary Share (NASDAQ: VRNA) had its price target raised by analysts at Piper Sandler from $76.00 to $160.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for VRNA provided by MarketBeat

